Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Frank

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Cytotherapy|October 4, 2020
Ex vivo-expanded highly pure ABCB5<sup>+</sup> mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human dataAndreas Kerstan, Elke Niebergall-Roth, Jasmina Esterlechner, et al.
Stem Cells (Dayton, Ohio)|April 20, 2019
Newly Defined ATP-Binding Cassette Subfamily B Member 5 Positive Dermal Mesenchymal Stem Cells Promote Healing of Chronic Iron-Overload Wounds via Secretion of Interleukin-1 Receptor AntagonistSeppe Vander Beken, Juliane C de Vries, Barbara Meier-Schiesser, et al.
Cell Reports|September 1, 2015
ABCB5 Identifies Immunoregulatory Dermal CellsTobias Schatton, Jun Yang, Sonja Kleffel, et al.
Stem Cell Research & Therapy|September 5, 2022
Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcersAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Nature|July 18, 2014
ABCB5 is a limbal stem cell gene required for corneal development and repairBruce R Ksander, Paraskevi E Kolovou, Brian J Wilson, et al.
JCI Insight|October 19, 2021
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosaDimitra Kiritsi, Kathrin Dieter, Elke Niebergall-Roth, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5<sup>+</sup> mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
NPJ Genomic Medicine|August 23, 2018
An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discoveryAlireza Haghighi, Joel B Krier, Agnes Toth-Petroczy, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Cytotherapy|October 4, 2020
Ex vivo-expanded highly pure ABCB5<sup>+</sup> mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human dataAndreas Kerstan, Elke Niebergall-Roth, Jasmina Esterlechner, et al.
Stem Cells (Dayton, Ohio)|April 20, 2019
Newly Defined ATP-Binding Cassette Subfamily B Member 5 Positive Dermal Mesenchymal Stem Cells Promote Healing of Chronic Iron-Overload Wounds via Secretion of Interleukin-1 Receptor AntagonistSeppe Vander Beken, Juliane C de Vries, Barbara Meier-Schiesser, et al.
Cell Reports|September 1, 2015
ABCB5 Identifies Immunoregulatory Dermal CellsTobias Schatton, Jun Yang, Sonja Kleffel, et al.
Stem Cell Research & Therapy|September 5, 2022
Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcersAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Nature|July 18, 2014
ABCB5 is a limbal stem cell gene required for corneal development and repairBruce R Ksander, Paraskevi E Kolovou, Brian J Wilson, et al.
JCI Insight|October 19, 2021
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosaDimitra Kiritsi, Kathrin Dieter, Elke Niebergall-Roth, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5<sup>+</sup> mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
NPJ Genomic Medicine|August 23, 2018
An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discoveryAlireza Haghighi, Joel B Krier, Agnes Toth-Petroczy, et al.
Pageof 14